Bao, Y., Oguz, G., Lee, W. C., Lee, P. L., Ghosh, K., Li, J., . . . Yu, Q. (2020). EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy. Nature Portfolio.
Cita Chicago Style (17a ed.)Bao, Yi, et al. EZH2-mediated PP2A Inactivation Confers Resistance to HER2-targeted Breast Cancer Therapy. Nature Portfolio, 2020.
Cita MLA (8a ed.)Bao, Yi, et al. EZH2-mediated PP2A Inactivation Confers Resistance to HER2-targeted Breast Cancer Therapy. Nature Portfolio, 2020.
Precaución: Estas citas no son 100% exactas.